Clifford Bechtold
About Clifford Bechtold
Clifford Bechtold is the Chief Operating Officer at Biohaven Pharmaceuticals and a Development Team Leader for Genetically Defined Diseases at Bristol-Myers Squibb, with over 30 years of experience in the pharmaceutical industry.
Title
Clifford Bechtold currently serves as the Development Team Leader for Genetically Defined Diseases at Bristol-Myers Squibb. He holds the position of Chief Operating Officer at Biohaven Pharmaceuticals.
Current Company: Biohaven Pharmaceuticals
Clifford Bechtold joined Biohaven Pharmaceuticals in October 2017. He operates as the Chief Operating Officer. With over three decades of experience in the pharmaceutical industry, Bechtold plays a crucial role in the operational management and strategic direction of the company.
Previous Roles at Bristol-Myers Squibb
Clifford Bechtold has held multiple roles at Bristol-Myers Squibb. Currently, he is the Development Team Leader, focusing on genetically defined diseases. Earlier, he managed biologics strategy and operations from 2011 to 2013. Prior to that, he took on various leadership responsibilities in discovery, clinical, and project management from 1991 to 2009.
Experience at Adnexus
From 2009 to 2011, Clifford Bechtold was the Vice President of Strategic Operations at Adnexus. In this role, he was responsible for overseeing strategic initiatives and operational processes within the organization.
Educational Background
Clifford Bechtold pursued his MS in Medical Microbiology at Creighton University School of Medicine, completing his studies from 1989 to 1991. Prior to that, he attended South Dakota State University from 1983 to 1987.